Lonza CHI获得NutraStrong胶原蛋白认证——营养视野网报道
Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com
生物技术与制药领域的最新动态
Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com
Executive changes at Lonza - The Pharma Letter
SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients - Nutraceutical Business Review
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands - PR Newswire
Future-proofing nutraceuticals: Lonza CHI on bioavailability and sensory appeal - nutritioninsight.com
Solving for solubility: Drug formulation for complex molecules - Nature
Lonza to Highlight Preservation and Disinfection Solutions - Nonwovens Industry -
Lonza Stover Obituary (2025) - St. Petersburg, Florida - Tampa Bay Times - Legacy | Obituary
Excellos, Lonza, and Akadeum Life Sciences Unite to Advance Cell Therapy Manufacturing Through Enhanced Starting Material Quality - PR Newswire
Three amigos: Lonza, Excellos, and Akadeum team to improve CGT landscape - BioProcess International
Preclinical pitfalls: How to avoid costly formulation failures - Nature
Lonza Group First Half 2025 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
Vacaville facility a standout in Lonza earnings report - The Vacaville Reporter
Lonza lifts forecast as performance rebounds under new strategy - The Pharma Letter
A Swiss company bought Genentech's Vacaville plant — here's how it's going so far - San Francisco Business Times - The Business Journals
Lonza tops core profit forecast driven by main drug manufacturing business - Reuters
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling - Fierce Pharma
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge - BioSpectrum Asia
Strategic planning in ADC development: insights from Lonza - Drug Target Review